Pharmafile Logo
Pharmafocus logo
Advanced Search

Vaccine

Showing 15 posts of 293 posts found.

astrazeneca_sign_sky

Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni

November 9, 2020
Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …

News
shutterstock_2

Australia secures a further 50m COVID-19 vaccine doses from Novavax and Pfizer/BioNTech

November 5, 2020
Manufacturing and Production Australia, COVID-19, Vaccine

Two more COVID-19 vaccine distribution deals have been signed by the Australian Government, reserving a further 50 million doses to …

News
takeda_usa_pharmaceuticals_u

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …

News
astrazeneca-sign

AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants

October 26, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine

AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of Oxford, has shown promising immune …

News
vaccination-1215279_960_720

Spain secures 31.6 million doses of AstraZeneca’s COVID-19 vaccine

October 21, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Spain, Vaccine

AstraZeneca continues to forge agreements with national governments to deliver its vaccine against COVID-19, with Spain becoming the latest country …

News

Pfizer won’t apply for COVID-19 vaccine emergency authorisation until after US election, CEO says

October 19, 2020
Sales and Marketing COVID-19, Pfizer, US, Vaccine

The Chief Executive Officer of Pfizer has said that the company will now submit their vaccine for FDA Emergency Use …

News
800px-roberto_fico_in_the_russian_state_duma_2019-03-05_03

Russia gives regulatory approval to second COVID-19 vaccine after early clinical trials

October 15, 2020
Research and Development COVID Vaccine, Vaccine, coronavirus vaccine

Russian President Vladimir Putin announced on Wednesday that regulators had given approval to a second coronavirus vaccine. This new vaccine …

News

J&J halts COVID-19 vaccine study following unidentified participant illness

October 13, 2020
Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma

Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …

News
injection-2248377_960_720

EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine

October 7, 2020
Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …

News
fda_21_4_1

White House halts release of new FDA standards for the Emergency Use Authorization of COVID-19 vaccine

October 6, 2020
Manufacturing and Production FDA, Trump, Vaccine, coronavirus vaccines

The Trump White House is blocking new federal guidance for the emergency release of coronavirus vaccines that would essentially ensure …

News
vaccination-1215279_960_720

IGT Biologika’s COVID-19 vaccine becomes third in Germany to be approved for human trials

October 2, 2020
Medical Communications, Research and Development COVID-19, IDT Biologika, Vaccine

German biotech IDT Biologika has become the third company in the country to secure approval from the nation’s vaccine regulator …

News
shutterstock_2

GSK confirms deal to supply 300 million COVID-19 vaccine doses to the EU

September 25, 2020
Manufacturing and Production, Medical Communications COVID-19, EU, GSK, Vaccine

GlaxoSmithKline has confirmed a new COVID-19 vaccine supply deal to deliver 300 million doses of its candidate to the European …

News
1

Science community calls for transparency on AstraZeneca’s halted US COVID-19 vaccine trial

September 23, 2020
Research and Development AstraZeneca, COVID-19, Vaccine

The halting of AstraZeneca’s COVID-19 vaccine trial around the world was cause for much initial concern over the eventual safety …

News
256px-mikhail_murashko_2020-01-29

One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister

September 18, 2020
Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine

Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …

News
gettyimages-1206570416

India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine

September 16, 2020
Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine

Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025